Impact of COVID-19 on Acute Appendicitis: Real-World Study at a Third-Level Hospital in Mexico City

COVID-19 对急性阑尾炎的影响:墨西哥城一家三级医院的真实世界研究

阅读:1

Abstract

Background Acute appendicitis (AA) is a common surgical emergency, with delayed diagnosis increasing the risk of complications. The COVID-19 pandemic disrupted healthcare access, potentially leading to more severe presentations of AA. This study assesses the pandemic's impact on the severity and outcomes of AA. Methods This retrospective cohort study analyzed patients diagnosed with AA at the American British Cowdray Medical Center from November 2019 to July 2020. The patients were categorized into pre-pandemic (before March 23, 2020) and post-pandemic (after March 24, 2020) groups. Demographics, laboratory findings, intraoperative classification with American Association for the Surgery of Trauma (AAST) grades I-V, histopathology, and duration of hospital stay were compared. Results Of the 192 patients included in the study, 119 were in the pre-pandemic group and 73 in the post-pandemic group. Although the post-pandemic group had longer symptom duration before hospital admission, the difference was not statistically significant (p=0.1078). However, the post-pandemic group had significantly more cases of complicated appendicitis (p=0.0012) and perforated appendicitis (p=0.0171). Histopathological analysis showed that post-pandemic patients were 1.8 times more likely to have complicated appendicitis (OR=1.8, 95% CI:1.3-2.6). The duration of hospital stay remained similar between groups (p=0.2957). Conclusions The COVID-19 pandemic led to delayed AA presentation and increased disease severity. Public health measures should stress the importance of prompt medical evaluation to prevent complications. Further studies are needed to explore additional factors influencing delays in surgical emergencies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。